Developer docs
API playgroundTry for free, no card

Search company profiles

Northwest Oncology & Hematology

Full company profile

uuid000nha8

Namestring
Northwest Oncology & Hematology
Legal namestring
Northwest Oncology & Hematology
Company typeenum
Private
Founded yearint
1978
Descriptiontext

Northwest Oncology & Hematology (NWOH) is a private outpatient medical oncology and hematology practice founded in 1978 and headquartered at 3701 Algonquin Rd., Rolling Meadows, Illinois. The practice treats adult and elderly cancer and hematology patients across four clinic locations in Rolling Meadows, Elk Grove Village, Hoffman Estates, and Barrington, serving the northwest suburbs of Chicago. The clinical team consists of 16 physicians and advanced practitioners, with a broader headcount of 51-100 employees. NWOH provides chemotherapy, hormone therapy, cancer immunotherapy (including targeted therapy and anti-angiogenesis therapy), prescription oral medications, and treatment for malignant and benign blood disorders. The practice treats a broad range of cancer types — lung, prostate, breast, gynecologic, colon, bladder, kidney, liver, head and neck, esophageal, leukemia, lymphoma, sarcoma — and offers access to clinical trials and a patient-facing Health Education Library. The practice is QOPI Certified by ASCO, satisfying the Quality Oncology Practice Initiative standards covering treatment planning, chemotherapy orders and drug preparation, safe administration, and patient monitoring.

NWOH generates revenue through professional services billing for outpatient oncology and hematology care, paid primarily via insurance reimbursements and patient pay. The practice operates a sales-led go-to-market: patients enter the practice either through physician referrals or via self-directed contact (phone or Phreesia-based online appointment forms). Distribution is delivered through four physical clinic locations with weekday hours and 24/7 on-call physician coverage, plus a CARESPACE patient portal and online payment systems. Marketing channels include the practice website, Facebook, LinkedIn, Twitter, online scheduling forms, and a Referring Provider Request Form. The practice also maintains hospital affiliations and emphasizes 30+ years of combined clinical experience as a differentiator alongside its QOPI quality certification.

The business is independently owned by its physician partners with no disclosed private equity, venture capital, or parent company involvement, and no disclosed funding rounds, M&A activity, or leadership transitions. NWOH self-describes as one of the largest private oncology practices in Chicago's northwest suburbs. Financials (revenue, profitability, payor mix) are not publicly disclosed.

Short descriptiontext

Northwest Oncology & Hematology is a private outpatient medical oncology and hematology practice founded in 1978, operating four clinics across Chicago's northwest suburbs and delivering chemotherapy, immunotherapy, hormone therapy, oral medications, and blood disorder treatment to adult cancer and hematology patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRolling Meadows, United States
HQ citystring
Rolling Meadows
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology medical services, hematology treatment, cancer care services, chemotherapy infusion, blood disorder treatment
Industry3 codes
1Medical Oncology
CodeHLAKAFABPrimaryYes
2Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryNo
3Medical Hematology (Benign Hematology)
CodeHLAKAFAAPrimaryNo
NAICS code2 codes
  • Offices of Physicians62111
  • Outpatient Care Centers6214
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Oncology and Hematology Medical Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Oncology and Hematology Services
TypeProfessional Services
Description

The practice generates revenue through the delivery of oncology and hematology medical services, including chemotherapy, hormone therapy, immunotherapy, and oral medication administration. Revenue is derived from insurance reimbursements, patient payments, and related medical billing for outpatient clinical services.

northwestoncology.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Northwest Oncology & Hematology is a private outpatient oncology and hematology practice delivering chemotherapy, hormone therapy, cancer immunotherapy, oral medications, and treatment for malignant and benign blood disorders. Care is provided by board-certified cancer specialists across four Illinois clinic locations (Rolling Meadows, Elk Grove Village, Hoffman Estates, and Barrington) with access to clinical trials, QOPI-certified quality standards, and 24/7 on-call physician coverage.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Northwest Oncology & Hematology is a healthcare practice providing comprehensive cancer care and hematology services. The practice offers a unified portfolio of treatment services centered around its core oncology offerings: Chemotherapy, Hormone Therapy, Cancer Immunotherapy, treatment for Malignant & Benign Blood Disorders, and Oral Medications. The Health Education Library serves as a patient education resource providing information on cancer types, diagnostic procedures, and treatment options. The practice has four office locations in Illinois (Rolling Meadows, Elk Grove Village, Hoffman Estates, and Barrington) serving the northwest suburban Chicago area since 1978.

Product and service5 records
1Chemotherapy
CategoryOncology Treatment Service
Description

Chemotherapy service using natural or manufactured drugs to weaken and destroy cancer cells at the original cancer site and any cells that have spread, delivered to patients at NWOH's Illinois clinic locations.

2Hormone Therapy
3Cancer Immunotherapy
4Malignant and Benign Blood Disorders Treatment
5Oral Medications
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeOthersAnnounced on2010-01-01
Description

Northwest Oncology & Hematology has been recognized by the Quality Oncology Practice Initiative (QOPI) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO). ASCO is the world's leading professional organization representing physicians who care for people with cancer, with more than 30,000 members. ASCO's QOPI program is a voluntary self-assessment and improvement program launched in 2006, and the QCP certification program was launched in January 2010. NWOH's QOPI certification demonstrates the practice meets rigorous safety measures and the highest standards of care for cancer patients.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Physician-led community oncology platform partnering with independent practices to provide capital, technology, and back-office scale; directly relevant as both a competitor and a strategic exit partner for NWOH.

TypeDirect peer
Description

Independent community oncology and hematology group operating multiple outpatient clinics with a similar service mix (chemo, immunotherapy, hematology, clinical trials); comparable business model and scale to NWOH.

TypeBroad incumbent
Description

Major Chicago-area academic health system with extensive oncology service lines; competes with NWOH for cancer patients in the northwest suburbs and is a likely acquirer of independent practices.

TypeBroad incumbent
Description

One of the largest U.S. community oncology networks, now part of McKesson, providing practice management, drug distribution, and technology to affiliated practices; a scaled incumbent against which NWOH competes for trials and physician talent.

TypeDirect peer
Description

Independent community oncology and hematology practice serving the Chicago suburbs with multiple locations, chemotherapy, immunotherapy, and clinical trials — directly comparable in service mix, geography, and target patient base to NWOH.

TypeBroad incumbent
Description

Nationally branded cancer care network now part of City of Hope; competes for high-acuity oncology patients in the Chicago region and offers a comparable portfolio of chemo, immunotherapy, and clinical trials.

TypeBroad incumbent
Description

Large regional health system operating hospitals and outpatient oncology services throughout the Chicago metro, overlapping geographically with NWOH and frequently acquiring independent oncology groups.

TypeEmerging player
Description

PE-backed oncology practice management platform aggregating independent community oncology practices across the U.S.; competes for physician partners and patient referrals in Chicago-area markets and represents both a competitor and a potential acquirer of NWOH.

TypeDirect peer
Description

Multi-site community oncology and hematology practice providing chemotherapy, immunotherapy, and clinical trials through a regional clinic network — a structural and operational analog to NWOH in a different geography.

TypeRegional player
Description

Multi-physician independent community oncology and hematology practice serving northeast Indiana; comparable in service mix and physician-owned independent model, though operating in a different regional market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Northwest Oncology & Hematology

Oncology and Hematology Medical Servicesnorthwestoncology.com

Northwest Oncology & Hematology is a private outpatient medical oncology and hematology practice founded in 1978, operating four clinics across Chicago's northwest suburbs and delivering chemotherapy, immunotherapy, hormone therapy, oral medications, and blood disorder treatment to adult cancer and hematology patients.

What Northwest Oncology & Hematology does

Northwest Oncology & Hematology (NWOH) is a private outpatient medical oncology and hematology practice founded in 1978 and headquartered at 3701 Algonquin Rd., Rolling Meadows, Illinois. The practice treats adult and elderly cancer and hematology patients across four clinic locations in Rolling Meadows, Elk Grove Village, Hoffman Estates, and Barrington, serving the northwest suburbs of Chicago. The clinical team consists of 16 physicians and advanced practitioners, with a broader headcount of 51-100 employees. NWOH provides chemotherapy, hormone therapy, cancer immunotherapy (including targeted therapy and anti-angiogenesis therapy), prescription oral medications, and treatment for malignant and benign blood disorders. The practice treats a broad range of cancer types — lung, prostate, breast, gynecologic, colon, bladder, kidney, liver, head and neck, esophageal, leukemia, lymphoma, sarcoma — and offers access to clinical trials and a patient-facing Health Education Library. The practice is QOPI Certified by ASCO, satisfying the Quality Oncology Practice Initiative standards covering treatment planning, chemotherapy orders and drug preparation, safe administration, and patient monitoring.

NWOH generates revenue through professional services billing for outpatient oncology and hematology care, paid primarily via insurance reimbursements and patient pay. The practice operates a sales-led go-to-market: patients enter the practice either through physician referrals or via self-directed contact (phone or Phreesia-based online appointment forms). Distribution is delivered through four physical clinic locations with weekday hours and 24/7 on-call physician coverage, plus a CARESPACE patient portal and online payment systems. Marketing channels include the practice website, Facebook, LinkedIn, Twitter, online scheduling forms, and a Referring Provider Request Form. The practice also maintains hospital affiliations and emphasizes 30+ years of combined clinical experience as a differentiator alongside its QOPI quality certification.

The business is independently owned by its physician partners with no disclosed private equity, venture capital, or parent company involvement, and no disclosed funding rounds, M&A activity, or leadership transitions. NWOH self-describes as one of the largest private oncology practices in Chicago's northwest suburbs. Financials (revenue, profitability, payor mix) are not publicly disclosed.

Northwest Oncology & Hematology firmographics

Firmographics
Name
Northwest Oncology & Hematology
Legal name
Northwest Oncology & Hematology
Website
https://northwestoncology.com
Company type
Private
Founded year
1978
Operating status
Operating
Headcount range
51–100 employees
Short description
Northwest Oncology & Hematology is a private outpatient medical oncology and hematology practice founded in 1978, operating four clinics across Chicago's northwest suburbs and delivering chemotherapy, immunotherapy, hormone therapy, oral medications, and blood disorder treatment to adult cancer and hematology patients.
Ownership category
akta.pro rank

Northwest Oncology & Hematology industry classification

Industry
Product category
Oncology and Hematology Medical Services
NAICS
Offices of Physicians (62111), Outpatient Care Centers (6214)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Medical Oncology (HLAKAFAB)
akta.pro secondary industries
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Hematology (Benign Hematology) (HLAKAFAA)

Keywords

  • Oncology medical services
  • Hematology treatment
  • Cancer care services
  • Chemotherapy infusion
  • Blood disorder treatment

Where Northwest Oncology & Hematology is headquartered

Location

Headquarters

HQ city
Rolling Meadows
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Northwest Oncology & Hematology business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Oncology and Hematology Services: The practice generates revenue through the delivery of oncology and hematology medical services, including chemotherapy, hormone therapy, immunotherapy, and oral medication administration. Revenue is derived from insurance reimbursements, patient payments, and related medical billing for outpatient clinical services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Northwest Oncology & Hematology product offering

Product offering

Core offering

Northwest Oncology & Hematology is a private outpatient oncology and hematology practice delivering chemotherapy, hormone therapy, cancer immunotherapy, oral medications, and treatment for malignant and benign blood disorders. Care is provided by board-certified cancer specialists across four Illinois clinic locations (Rolling Meadows, Elk Grove Village, Hoffman Estates, and Barrington) with access to clinical trials, QOPI-certified quality standards, and 24/7 on-call physician coverage.

Product overview

Northwest Oncology & Hematology is a healthcare practice providing comprehensive cancer care and hematology services. The practice offers a unified portfolio of treatment services centered around its core oncology offerings: Chemotherapy, Hormone Therapy, Cancer Immunotherapy, treatment for Malignant & Benign Blood Disorders, and Oral Medications. The Health Education Library serves as a patient education resource providing information on cancer types, diagnostic procedures, and treatment options. The practice has four office locations in Illinois (Rolling Meadows, Elk Grove Village, Hoffman Estates, and Barrington) serving the northwest suburban Chicago area since 1978.

Differentiator

Problem solved

Functional benefit

Products and services

  • Chemotherapy Chemotherapy service using natural or manufactured drugs to weaken and destroy cancer cells at the original cancer site and any cells that have spread, delivered to patients at NWOH's Illinois clinic locations.
  • Hormone Therapy
  • Cancer Immunotherapy
  • Malignant and Benign Blood Disorders Treatment
  • Oral Medications

Companies that use Northwest Oncology & Hematology

Customer profile

Segments1 record

Ideal customer profiles1 record

Northwest Oncology & Hematology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Northwest Oncology & Hematology partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • American Society of Clinical Oncology (ASCO)flagshipOthers · 1 January 2010Northwest Oncology & Hematology has been recognized by the Quality Oncology Practice Initiative (QOPI) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO). ASCO is the world's leading professional organization representing physicians who care for people with cancer, with more than 30,000 members. ASCO's QOPI program is a voluntary self-assessment and improvement program launched in 2006, and the QCP certification program was launched in January 2010. NWOH's QOPI certification demonstrates the practice meets rigorous safety measures and the highest standards of care for cancer patients.

Scale indicators3 records

Recent moves5 records

Expansion highlights2 records

Northwest Oncology & Hematology competitors and assessment

Company assessment

Emerging players

  • OneOncology: Physician-led community oncology platform partnering with independent practices to provide capital, technology, and back-office scale; directly relevant as both a competitor and a strategic exit partner for NWOH.
  • American Oncology Network: PE-backed oncology practice management platform aggregating independent community oncology practices across the U.S.; competes for physician partners and patient referrals in Chicago-area markets and represents both a competitor and a potential acquirer of NWOH.

Direct peers

  • The Center for Cancer and Blood Disorders: Independent community oncology and hematology group operating multiple outpatient clinics with a similar service mix (chemo, immunotherapy, hematology, clinical trials); comparable business model and scale to NWOH.
  • Illinois Cancer Specialists: Independent community oncology and hematology practice serving the Chicago suburbs with multiple locations, chemotherapy, immunotherapy, and clinical trials — directly comparable in service mix, geography, and target patient base to NWOH.
  • Arizona Oncology: Multi-site community oncology and hematology practice providing chemotherapy, immunotherapy, and clinical trials through a regional clinic network — a structural and operational analog to NWOH in a different geography.

Broad incumbents

  • Northwestern Medicine: Major Chicago-area academic health system with extensive oncology service lines; competes with NWOH for cancer patients in the northwest suburbs and is a likely acquirer of independent practices.
  • US Oncology Network (McKesson): One of the largest U.S. community oncology networks, now part of McKesson, providing practice management, drug distribution, and technology to affiliated practices; a scaled incumbent against which NWOH competes for trials and physician talent.
  • Cancer Treatment Centers of America (City of Hope): Nationally branded cancer care network now part of City of Hope; competes for high-acuity oncology patients in the Chicago region and offers a comparable portfolio of chemo, immunotherapy, and clinical trials.
  • Advocate Health Care: Large regional health system operating hospitals and outpatient oncology services throughout the Chicago metro, overlapping geographically with NWOH and frequently acquiring independent oncology groups.

Regional players

  • Fort Wayne Medical Oncology and Hematology: Multi-physician independent community oncology and hematology practice serving northeast Indiana; comparable in service mix and physician-owned independent model, though operating in a different regional market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Northwest Oncology & Hematology social profiles

Digital presence

Northwest Oncology & Hematology compliance and trust

Trust signal

Compliance1 record

Northwest Oncology & Hematology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Northwest Oncology & Hematology leadership team

Management profile

Number of profiles

Profiles1 record

Northwest Oncology & Hematology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Northwest Oncology & Hematology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Northwest Oncology & Hematology

What does Northwest Oncology & Hematology do?

Northwest Oncology & Hematology is a private outpatient oncology and hematology practice delivering chemotherapy, hormone therapy, cancer immunotherapy, oral medications, and treatment for malignant and benign blood disorders. Care is provided by board-certified cancer specialists across four Illinois clinic locations (Rolling Meadows, Elk Grove Village, Hoffman Estates, and Barrington) with access to clinical trials, QOPI-certified quality standards, and 24/7 on-call physician coverage.

Is Northwest Oncology & Hematology a public or private company?

Northwest Oncology & Hematology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Northwest Oncology & Hematology founded?

Northwest Oncology & Hematology was founded in 1978. It employs 51 to 100 people.

Where is Northwest Oncology & Hematology based?

Northwest Oncology & Hematology is headquartered in Rolling Meadows, United States, in the North America region.

How does Northwest Oncology & Hematology make money?

One revenue line is on record: clinical Oncology and Hematology Services.

Who are Northwest Oncology & Hematology's main competitors?

Emerging players on record are OneOncology and American Oncology Network. Direct peers are The Center for Cancer and Blood Disorders, Illinois Cancer Specialists and Arizona Oncology. Broad incumbents are Northwestern Medicine, US Oncology Network (McKesson), Cancer Treatment Centers of America (City of Hope) and Advocate Health Care. Fort Wayne Medical Oncology and Hematology is listed as a regional player.

Does Northwest Oncology & Hematology have an API?

No public API is recorded for Northwest Oncology & Hematology.

What industry is Northwest Oncology & Hematology in?

Northwest Oncology & Hematology's product category is Oncology and Hematology Medical Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals